{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:20:28Z","timestamp":1788790828439,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12916-018-1134-3","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T11:02:12Z","timestamp":1536145332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4105-9669","authenticated-orcid":false,"given":"P.","family":"Bruijning-Verhagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A. P.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D. M.","family":"Verberk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pijnacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. D.","family":"van Gaalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Klinkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-J. J.","family":"Mangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"1134_CR1","doi-asserted-by":"crossref","unstructured":"Hahne S, Hooiveld M, Vennema H, van Ginkel A, de Melker H, Wallinga J, van Pelt W, Bruijning-Verhagen P. Exceptionally low rotavirus incidence in the Netherlands in 2013\/14 in the absence of rotavirus vaccination. Euro Surveill. 2014;19(43).","DOI":"10.2807\/1560-7917.ES2014.19.43.20945"},{"key":"1134_CR2","first-page":"1","volume-title":"RIVM Report","author":"JDM Verberk","year":"2017","unstructured":"Verberk JDM, Bruijning-Verhagen P, de Melker HE. Rotavirus in the Netherlands; background information for the Health Council. In: RIVM Report. Bilthoven: National Institute of Public Health and the Environment; 2017. p. 1\u201370."},{"key":"1134_CR3","volume-title":"State of Infectious Diseases in the Netherlands","author":"National Institute for Public Health and the Environment","year":"2016","unstructured":"National Institute for Public Health and the Environment. State of Infectious Diseases in the Netherlands, 2016. \n                    http:\/\/www.rivm.nl\/dsresource?objectid=bce6439b-ce72-49d3-b7ed-e0c42348c8c5&type=pdf&disposition=inline\n                    \n                  ."},{"issue":"2","key":"1134_CR4","doi-asserted-by":"publisher","first-page":"e89496","DOI":"10.1371\/journal.pone.0089496","volume":"9","author":"R Enserink","year":"2014","unstructured":"Enserink R, Scholts R, Bruijning-Verhagen P, Duizer E, Vennema H, de Boer R, Kortbeek T, Roelfsema J, Smit H, Kooistra-Smid M, et al. High detection rates of enteropathogens in asymptomatic children attending day care. PLoS One. 2014;9(2):e89496.","journal-title":"PLoS One"},{"key":"1134_CR5","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. RIVM Virologische Weekstaten, Open Rapportages [\n                    http:\/\/www.rivm.nl\/Onderwerpen\/V\/Virologische_weekstaten\/Rapportages\/Open_rapportages_virologische_weekstaten\/Virologische_uitslagen_per_week_sinds_2006_grafieken\n                    \n                  ]."},{"issue":"4","key":"1134_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/EDE.0000000000000654","volume":"28","author":"RD van Gaalen","year":"2017","unstructured":"van Gaalen RD, van de Kassteele J, Hahne SJM, Bruijning-Verhagen P, Wallinga J. Determinants of rotavirus transmission: a lag nonlinear time series analysis. Epidemiology. 2017;28(4):503\u201313.","journal-title":"Epidemiology"},{"issue":"20","key":"1134_CR7","doi-asserted-by":"publisher","first-page":"20806","DOI":"10.2807\/1560-7917.ES2014.19.20.20806","volume":"19","author":"T Braeckman","year":"2014","unstructured":"Braeckman T, Theeten H, Lernout T, Hens N, Roelants M, Hoppenbrouwers K, Van Damme P. Rotavirus vaccination coverage and adherence to recommended age among infants in Flanders (Belgium) in 2012. Euro Surveill. 2014;19(20:pii=20806)","journal-title":"Eurosurveillance"},{"key":"1134_CR8","unstructured":"Rieck T, Wichmann O, Siedler A. Aktuelles aus der KV-Impfsurveillance; Impfquoten der rotavirus-, Masern-, HPV- und Influenza-Impfung in Deutschland. Epidemiologisches Bulletin. 2017;2017(1)"},{"key":"1134_CR9","unstructured":"Public Health England. National rotavirus immunisation programme update: preliminary vaccine coverage for England, February 2016 to July 2016. In: Infection Report. vol. 10 Number 32: Health Protection Report; 2016."},{"issue":"4","key":"1134_CR10","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1080\/21645515.2017.1412019","volume":"14","author":"MLA de Hoog","year":"2018","unstructured":"de Hoog MLA, Vesikari T, Giaquinto C, Huppertz HI, Martinon-Torres F, Bruijning-Verhagen P. Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC). Hum Vaccin Immunother. 2018;14(4):1027\u201334.","journal-title":"Hum Vaccin Immunother"},{"key":"1134_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1741-7015-11-112","volume":"11","author":"P Bruijning-Verhagen","year":"2013","unstructured":"Bruijning-Verhagen P, Mangen MJ, Felderhof M, Hartwig NG, van Houten M, Winkel L, de Waal WJ, Bonten MJ. Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination. BMC Med. 2013;11:112.","journal-title":"BMC Med"},{"issue":"7","key":"1134_CR12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/aje\/154.7.666","volume":"154","author":"MA de Wit","year":"2001","unstructured":"de Wit MA, Koopmans MP, Kortbeek LM, Wannet WJ, Vinje J, van Leusden F, Bartelds AI, van Duynhoven YT. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. Am J Epidemiol. 2001;154(7):666\u201374.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1134_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3201\/eid0701.010113","volume":"7","author":"MA de Wit","year":"2001","unstructured":"de Wit MA, Koopmans MP, Kortbeek LM, van Leeuwen NJ, Bartelds AI, van Duynhoven YT. Gastroenteritis in sentinel general practices, The Netherlands. Emerg Infect Dis. 2001;7(1):82\u201391.","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"1134_CR14","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1097\/INF.0b013e31826a5ba1","volume":"31","author":"P Bruijning-Verhagen","year":"2012","unstructured":"Bruijning-Verhagen P, Sankatsing V, Kunst A, van den Born C, Bleeker E, Thijsen S, Ijzerman EP, van der Velden VH, Bonten MJ. Rotavirus-related hospitalizations are responsible for high seasonal peaks in all-cause pediatric hospitalizations. Pediatr Infect Dis J. 2012;31(12):e244\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"1134_CR15","unstructured":"National Institute for Public Heath and the Environment. The National Immunisation Programme in the Netherlands: developments in 2009 [\n                    http:\/\/www.rivm.nl\/bibliotheek\/rapporten\/210021012.pdf\n                    \n                  ]."},{"key":"1134_CR16","volume-title":"The national immunisation programme in the Netherlands: surveillance and developments in 2015-2016","author":"TM Schurink-van\u2019 t Klooster","year":"2016","unstructured":"Schurink-van\u2019 t Klooster TM, de Melker HEE. The national immunisation programme in the Netherlands: surveillance and developments in 2015-2016. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2016."},{"issue":"14","key":"1134_CR17","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.vaccine.2010.01.014","volume":"28","author":"MJ Mangen","year":"2010","unstructured":"Mangen MJ, van Duynhoven YT, Vennema H, van Pelt W, Havelaar AH, de Melker HE. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? Vaccine. 2010;28(14):2624\u201335.","journal-title":"Vaccine"},{"key":"1134_CR18","first-page":"85","volume-title":"5th European Expert Meeting on Rotavirus Vaccination: March 20-22nd, 2017 2017; Utrecht","author":"F van Dongen","year":"2017","unstructured":"van Dongen F, Schuurman R, Bonten MJM, Study-Group ObotR. Rotavirus hospitalizations in the absence of rotavirus vaccine in 2015\u20132016 in the Netherlands. In: 5th European Expert Meeting on Rotavirus Vaccination: March 20-22nd, 2017 2017; Utrecht; 2017. p. 85."},{"key":"1134_CR19","unstructured":"RIVAR-project: Risk-Group Infant Vaccination Against Rotavirus. [\n                    http:\/\/portal.juliuscentrum.nl\/research\/nl-NL\/cohortsandprojects\/cohortsprojects\/rivar.aspx\n                    \n                  ]."},{"issue":"39","key":"1134_CR20","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1016\/j.vaccine.2015.07.012","volume":"33","author":"R Marlow","year":"2015","unstructured":"Marlow R, Finn A, Trotter C. Quality of life impacts from rotavirus gastroenteritis on children and their families in the UK. Vaccine. 2015;33(39):5212\u20136.","journal-title":"Vaccine"},{"key":"1134_CR21","first-page":"83","volume-title":"5th European Expert Meeting on Rotavirus Vaccination: March 20-22nd, 2017 2017; Utrecht","author":"F Quee","year":"2017","unstructured":"Quee F, de Hoog MLA, Schuurman R, Bruijning-Verhagen P. A comparison of incidence, transmission and burden of norovirus and rotavirus infections among young families in the Netherlands. In: 5th European Expert Meeting on Rotavirus Vaccination: March 20-22nd, 2017 2017; Utrecht; 2017. p. 83\u20134."},{"key":"1134_CR22","volume-title":"Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg","author":"ZIN","year":"2015","unstructured":"ZIN. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. Diemen: Zorginstituut Nederland (ZIN); 2015. Geactualiseerde versie 2015"},{"issue":"4","key":"1134_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/infdis\/jiw186","volume":"214","author":"M Prelog","year":"2016","unstructured":"Prelog M, Gorth P, Zwazl I, Kleines M, Streng A, Zlamy M, Heinz-Erian P, Wiedermann U. Universal mass vaccination against rotavirus: indirect effects on rotavirus infections in neonates and unvaccinated young infants not eligible for vaccination. J Infect Dis. 2016;214(4):546\u201355.","journal-title":"J Infect Dis"},{"issue":"2","key":"1134_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/infdis\/jiv398","volume":"213","author":"CJ Atchison","year":"2016","unstructured":"Atchison CJ, Stowe J, Andrews N, Collins S, Allen DJ, Nawaz S, Brown D, Ramsay ME, Ladhani SN. Rapid declines in age group-specific rotavirus infection and acute gastroenteritis among vaccinated and unvaccinated individuals within 1 year of rotavirus vaccine introduction in England and Wales. J Infect Dis. 2016;213(2):243\u20139.","journal-title":"J Infect Dis"},{"issue":"8","key":"1134_CR25","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.4161\/hv.29511","volume":"10","author":"G Krishnarajah","year":"2014","unstructured":"Krishnarajah G, Demissie K, Lefebvre P, Gaur S, Sheng Duh M. Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States. Hum Vaccin Immunother. 2014;10(8):2255\u201366.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"1134_CR26","doi-asserted-by":"publisher","first-page":"e20161173","DOI":"10.1542\/peds.2016-1173","volume":"138","author":"HW Kaufman","year":"2016","unstructured":"Kaufman HW, Chen Z. Trends in laboratory rotavirus detection: 2003 to 2014. Pediatrics. 2016;138(4):e20161173.","journal-title":"Pediatrics"},{"key":"1134_CR27","doi-asserted-by":"crossref","unstructured":"Sabbe M, Berger N, Blommaert A, Ogunjimi B, Grammens T, Callens M, Van Herck K, Beutels P, Van Damme P, Bilcke J. Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014. Euro Surveill. 2016;21","DOI":"10.2807\/1560-7917.ES.2016.21.27.30273"},{"issue":"47","key":"1134_CR28","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1016\/j.vaccine.2014.09.004","volume":"32","author":"J Veldwijk","year":"2014","unstructured":"Veldwijk J, Lambooij MS, Bruijning-Verhagen PC, Smit HA, de Wit GA. Parental preferences for rotavirus vaccination in young children: a discrete choice experiment. Vaccine. 2014;32(47):6277\u201383.","journal-title":"Vaccine"},{"key":"1134_CR29","unstructured":"Zorginstituut Nederland. Medicijnkosten.nl. [\n                    https:\/\/www.medicijnkosten.nl\/databank?artikelId=7083&hoeveelheid=1,00\n                    \n                  ]."},{"key":"1134_CR30","volume-title":"Toedieningskosten per vaccinatie - H006: neventarief 0 tot 5 jarige - Nederlandse Zorgautoriteit Rekenstaat 2014 tariefbeschikking","author":"Nederlandse Zorgautoriteit","year":"2014","unstructured":"Nederlandse Zorgautoriteit. Toedieningskosten per vaccinatie - H006: neventarief 0 tot 5 jarige - Nederlandse Zorgautoriteit Rekenstaat 2014 tariefbeschikking. Utrecht: Nederlandse Zorgautoriteit; 2014."},{"key":"1134_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/1471-2458-11-462","volume":"11","author":"MH Rozenbaum","year":"2011","unstructured":"Rozenbaum MH, Mangen MJ, Giaquinto C, Wilschut JC, Hak E, Postma MJ, Consensus Group on Dutch Rotavirus V. Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model. BMC Public Health. 2011;11:462.","journal-title":"BMC Public Health"},{"issue":"3","key":"1134_CR32","doi-asserted-by":"publisher","first-page":"e0144812","DOI":"10.1371\/journal.pone.0144812","volume":"11","author":"T Leino","year":"2016","unstructured":"Leino T, Ollgren J, Stromberg N, Elonsalo U. Evaluation of the intussusception risk after pentavalent rotavirus vaccination in Finnish infants. PLoS One. 2016;11(3):e0144812.","journal-title":"PLoS One"},{"issue":"32","key":"1134_CR33","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1016\/j.vaccine.2016.04.050","volume":"34","author":"J Stowe","year":"2016","unstructured":"Stowe J, Andrews N, Ladhani S, Miller E. The risk of intussusception following monovalent rotavirus vaccination in England: a self-controlled case-series evaluation. Vaccine. 2016;34(32):3684\u20139.","journal-title":"Vaccine"},{"issue":"11","key":"1134_CR34","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1586\/14760584.2014.942223","volume":"13","author":"B Rha","year":"2014","unstructured":"Rha B, Tate JE, Weintraub E, Haber P, Yen C, Patel M, Cortese MM, DeStefano F, Parashar UD. Intussusception following rotavirus vaccination: an updated review of the available evidence. Expert Rev Vaccines. 2014;13(11):1339\u201348.","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"1134_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00103-013-1893-0","volume":"57","author":"D Oberle","year":"2014","unstructured":"Oberle D, Jenke AC, von Kries R, Mentzer D, Keller-Stanislawski B. Rotavirus vaccination: a risk factor for intussusception? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(2):234\u201341.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"1","key":"1134_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/1753-6405.12297","volume":"39","author":"R Palupi-Baroto","year":"2015","unstructured":"Palupi-Baroto R, Lee KJ, Carlin JB, Bines JE. Intussusception in Australia: epidemiology prior to the introduction of rotavirus vaccine. Aust N Z J Public Health. 2015;39(1):11\u20134.","journal-title":"Aust N Z J Public Health"},{"key":"1134_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.vaccine.2016.11.056","volume":"35","author":"JF Reyes","year":"2017","unstructured":"Reyes JF, Wood JG, Beutels P, Macartney K, McIntyre P, Menzies R, Mealing N, Newall AT. Beyond expectations: post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine. 2017;35:345\u201352.","journal-title":"Vaccine"},{"key":"1134_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijfoodmicro.2014.11.022","volume":"196","author":"MJ Mangen","year":"2015","unstructured":"Mangen MJ, Bouwknegt M, Friesema IH, Haagsma JA, Kortbeek LM, Tariq L, Wilson M, van Pelt W, Havelaar AH. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011. Int J Food Microbiol. 2015;196:84\u201393.","journal-title":"Int J Food Microbiol"},{"key":"1134_CR39","volume-title":"WHO guide to cost-effectiveness analysis","author":"T Tan-Torres Edejer","year":"2003","unstructured":"Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, Murray CJL. WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003."},{"key":"1134_CR40","unstructured":"National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. [\n                    https:\/\/www.nice.org.uk\/process\/pmg9\/chapter\/the-appraisal-of-the-evidence-and-structured-decision-making\n                    \n                  ]."},{"key":"1134_CR41","volume-title":"Threshold values for costeffectiveness in health care health technology assessment (HTA)","author":"I Cleemput","year":"2008","unstructured":"Cleemput I, Neyt M, Thiry N, De Laet C, Leys M. Threshold values for costeffectiveness in health care health technology assessment (HTA). Brussels: Belgian Health Care Knowledge Centre; 2008."},{"issue":"9","key":"1134_CR42","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1056\/NEJMp1405158","volume":"371","author":"PJ Neumann","year":"2014","unstructured":"Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014;371(9):796\u20137.","journal-title":"N Engl J Med"},{"issue":"5","key":"1134_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1473-3099(14)70035-0","volume":"14","author":"N Parez","year":"2014","unstructured":"Parez N, Giaquinto C, Du Roure C, Martinon-Torres F, Spoulou V, Van Damme P, Vesikari T. Rotavirus vaccination in Europe: drivers and barriers. Lancet Infect Dis. 2014;14(5):416\u201325.","journal-title":"Lancet Infect Dis"},{"key":"1134_CR44","first-page":"1","volume-title":"Avis et rapports de HCSP","author":"Publique HCdlS","year":"2015","unstructured":"Publique HCdlS. Infections \u00e0 rotavirus : suspension des recommandations de vaccination des nourrissons [rotavirus infections; recommendation for infant vaccination suspended]. In: Avis et rapports de HCSP. Paris: Haut Conseil de la Sante Publique (HCSP); 2015. p. 1\u20135."},{"issue":"8","key":"1134_CR45","doi-asserted-by":"publisher","first-page":"e42320","DOI":"10.1371\/journal.pone.0042320","volume":"7","author":"VE Pitzer","year":"2012","unstructured":"Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, Atchison CJ, Harris JP, Shim E, Galvani AP, Edmunds WJ, Viboud C, et al. Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One. 2012;7(8):e42320.","journal-title":"PLoS One"},{"key":"1134_CR46","unstructured":"Centraal Bureau voor de Statistiek. Levensverwachting; geslacht, leeftijd (per jaar en periode van vijf jaren). [\n                    http:\/\/statline.cbs.nl\/Statweb\/publication\/?DM=SLNL&PA=37360ned&D1=3&D2=a&D3=a&D4=95&HDR=G1\n                    \n                  ,T&STB=G2,G3&VW=T]."},{"key":"1134_CR47","volume-title":"Perinatal care in the Netherlands 2008","author":"Global Health Data Exchange","year":"2008","unstructured":"Global Health Data Exchange. Perinatal care in the Netherlands 2008. 2008."},{"issue":"1","key":"1134_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/INF.0b013e3181b41506","volume":"29","author":"M Brisson","year":"2010","unstructured":"Brisson M, S\u00e9n\u00e9cal M, Drolet M, Mansi JA. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. Pediatr Infect Dis J. 2010;29(1):73\u20135.","journal-title":"Pediatr Infect Dis J"},{"issue":"47","key":"1134_CR49","doi-asserted-by":"publisher","first-page":"7457","DOI":"10.1016\/j.vaccine.2010.08.060","volume":"28","author":"M Jit","year":"2010","unstructured":"Jit M, Mangen MJ, Melliez H, Yazdanpanah Y, Bilcke J, Salo H, Edmunds WJ, Beutels P. An update to \u201cThe cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe\u201d. Vaccine. 2010;28(47):7457\u20139.","journal-title":"Vaccine"},{"issue":"8","key":"1134_CR50","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s10096-011-1518-1","volume":"31","author":"IH Friesema","year":"2012","unstructured":"Friesema IH, Lugner AK, van Duynhoven YT, Group GEW. Costs of gastroenteritis in the Netherlands, with special attention for severe cases. Eur J Clin Microbiol Infect Dis. 2012;31(8):1895\u2013900.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"1134_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1017\/S0950268803001559","volume":"132","author":"WE van den Brandhof","year":"2004","unstructured":"van den Brandhof WE, De Wit GA, de Wit MA, van Duynhoven YT. Costs of gastroenteritis in the Netherlands. Epidemiol Infect. 2004;132(2):211\u201321.","journal-title":"Epidemiol Infect"},{"issue":"8","key":"1134_CR52","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1017\/S0950268812002166","volume":"141","author":"JA Haagsma","year":"2013","unstructured":"Haagsma JA, Geenen PL, Ethelberg S, Fetsch A, Hansdotter F, Jansen A, Korsgaard H, O'Brien SJ, Scavia G, Spitznagel H, et al. Community incidence of pathogen-specific gastroenteritis: reconstructing the surveillance pyramid for seven pathogens in seven European Union member states. Epidemiol Infect. 2013;141(8):1625\u201339.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"1134_CR53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/gutjnl-2012-303376","volume":"63","author":"ME van der Valk","year":"2014","unstructured":"van der Valk ME, Mangen MJ, Leenders M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, Pierik M, van der Woude CJ, Romberg-Camps MJ, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF\u03b1 therapy: results from the COIN study. Gut. 2014;63(1):72\u20139.","journal-title":"Gut"},{"key":"1134_CR54","unstructured":"(Statistiek) SNCBvd: Beroepsbevolking; kerncijfers naar geslacht en andere kenmerken 1996\u20132014. 13 Februar 2015 edn; 2015."},{"key":"1134_CR55","unstructured":"Vesikari T, Dennehy P, Matson D, Itzler R, Dallas M, Goveia M, DiNubile M, Heaton P, Lawrence J, Ciarlet M. Efficacy of Rotateq\u00ae, the pentavalent rotavirus vaccine, between doses: potential benefits of early protection [abstract]. Arch Dis Child. 2008;93:pw 70."},{"issue":"3","key":"1134_CR56","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.vaccine.2009.10.041","volume":"28","author":"T Vesikari","year":"2009","unstructured":"Vesikari T, Itzler R, Karvonen A, Korhonen T, Van DP, Behre U, Bona G, Gothefors L, Heaton PM, Dallas M, et al. RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe. Vaccine. 2009;28(3):345\u201351.","journal-title":"Vaccine"},{"issue":"11","key":"1134_CR57","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00431-010-1242-3","volume":"169","author":"T Vesikari","year":"2010","unstructured":"Vesikari T, Karvonen A, Ferrante SA, Ciarlet M. Efficacy of the pentavalent rotavirus vaccine, RotaTeq(R), in Finnish infants up to 3 years of age: the Finnish Extension Study. Eur J Pediatr. 2010;169(11):1379\u201386.","journal-title":"Eur J Pediatr"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1134-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-018-1134-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1134-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T19:06:00Z","timestamp":1568055960000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-018-1134-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1134"],"URL":"https:\/\/doi.org\/10.1186\/s12916-018-1134-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"23 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PB-V has received a research grant from GlaxoSmithKline for an investigator-initiated study on rotavirus vaccination in medical risk infants. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"168"}}